Copyright
©The Author(s) 2021.
World J Gastrointest Surg. Sep 27, 2021; 13(9): 1025-1038
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1025
Published online Sep 27, 2021. doi: 10.4240/wjgs.v13.i9.1025
Table 3 Morbidity and mortality between two groups in patients with distal cholangiocarcinoma
| Variables | Group 1 (n = 81) | Group 2 (n = 105) | P |
| Postoperative hospital stay (d) | 21 (16–24) | 20 (16–29) | 0.368 |
| In-hospital death | 1 | 6 | 0.229 |
| Complications | 20 | 34 | 0.252 |
| Biochemical fistula | 12 | 7 | 0.069 |
| Pancreatic fistula | |||
| Grade B | 4 | 2 | 0.458 |
| Grade C | 3 | 4 | 0.726 |
| Delayed gastric emptying | 2 | 6 | 0.473 |
| Intra-abdominal infection | 7 | 9 | 0.986 |
| Abdominal hemorrhage | 4 | 7 | 0.856 |
- Citation: Jiang T, Lyu SC, Zhou L, Wang J, Li H, He Q, Lang R. Carbohydrate antigen 19-9 as a novel prognostic biomarker in distal cholangiocarcinoma. World J Gastrointest Surg 2021; 13(9): 1025-1038
- URL: https://www.wjgnet.com/1948-9366/full/v13/i9/1025.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v13.i9.1025